Invention Grant
- Patent Title: Genetically modified mice expressing humanized PD-1
-
Application No.: US16313819Application Date: 2017-06-27
-
Publication No.: US10912287B2Publication Date: 2021-02-09
- Inventor: Yuelei Shen , Yang Bai , Rui Huang , Xiaofei Zhou , Yuting Hu , Yanan Guo , Jichao Du
- Applicant: Biocytogen Pharmaceuticals (Beijing) Co., Ltd
- Applicant Address: CN Beijing
- Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd
- Current Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd
- Current Assignee Address: CN Beijing
- Agency: Fish & Richardson P.C.
- Priority: CN201610487764 20160628
- International Application: PCT/CN2017/090320 WO 20170627
- International Announcement: WO2018/001241 WO 20180104
- Main IPC: A01K67/027
- IPC: A01K67/027 ; G01N33/00 ; C12N15/00 ; A61D19/04 ; A61K49/00 ; C07K14/705 ; C12N9/22 ; C12N15/11 ; C12N15/85

Abstract:
Provided is a method for preparing a PD-1 gene-modified humanized animal model. The method utilizes the CRIPSR/Cas9 technique to replace partial fragments of a mouse PD-1 gene with fragments of a human PD-1 gene using homologous recombination by constructing a targeting vector, thereby preparing a gene-modified humanized mouse. This mouse can normally express a PD-1 protein containing the functional domain of the human PD-1 protein, and can be used as an animal model for mechanism research regarding PD-1, PD-L1 and other signals, for screening regulators, and for toxicological research. The method has an important and high application value in studies on functions of the PD-1 gene and in the development of new drugs.
Public/Granted literature
- US20190387724A1 Method for Constructing PD-1 Gene Modified Humanized Animal Model and Use Thereof Public/Granted day:2019-12-26
Information query